Screener
Health Catalyst HCAT Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 50.5%+5.2pp | 49.9%+4.7pp | 48.7%+2.8pp | 46.5%+1.3pp | 45.3%+0.4pp | |
| Operating margin | -84.4%-56.4pp | -81.7%-60.1pp | -51.7%-28.9pp | -29.2%-1.0pp | -28%+4.1pp | |
| Net margin | -90.6%-58.9pp | -87.7%-64.4pp | -57.2%-34.5pp | -34.1%-7.9pp | -31.7%-2.8pp | |
| Returns | ||||||
| Return on equity | -118.1%-89.7pp | -103%-83.2pp | -58.3%-39.3pp | -31.3%-9.9pp | -28.4%-5.3pp | |
| Return on invested capital | -72.5%-45.1pp | -72.1%-56.1pp | -36.4%-22.8pp | -21.6%-3.2pp | -27.4%0.0pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.7×+0.9× | 1.7×+0.4× | 1.9×+0.5× | 1.9×+0.5× | 1.8×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 1.7×+1.2× | 1.2×+0.2× | 0.7×-0.4× | 0.5×-0.5× | 0.5×+0.4× | |
| Per Share | ||||||
| Book value per share | $1.36-72.7% | $1.90-65.4% | $3.52-42.1% | $4.72-19.7% | $4.99-17.1% | |
| Valuation | ||||||
| Market capitalization | $119.66M-53.9% | $93.45M-70.6% | $169.05M-60.7% | $200.56M-59.3% | $260.66M-30.9% | |
| Price / sales | 0.4×-0.4× | 0.3×-0.7× | 0.5×-0.9× | 0.6×-1.0× | 0.8×-0.4× | |
| Price / book | 1.2×+0.4× | 0.7×-0.2× | 0.7×-0.5× | 0.6×-0.8× | 0.8×-0.3× |
FAQ
- What are Health Catalyst's profit margins?
- Health Catalyst (HCAT) runs a 50.5% gross margin and a -84.4% operating margin, with a -90.6% net margin.
- Where do Health Catalyst's ratios come from?
- Every ratio is computed from Health Catalyst's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
